Yariv Houvras
CHIEF MEDICAL OFFICER · Xilio Therapeutics, Inc.
Individual
- 2026
- Oct 2, 2026
- 1
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Yariv Houvras files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- GILEAD SCIENCES, INC. - $2.00M in XLO purchases and sales in the last 12 months
- James Samuel Shannon - $44K in XLO purchases and sales in the last 12 months
- Christopher James Frankenfield - $5K in XLO purchases and sales in the last 12 months
- Kevin M. Brennan - $1K in XLO purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Yariv Houvras?
Yariv Houvras is a corporate insider, tracked as CHIEF MEDICAL OFFICER of Xilio Therapeutics, Inc. (XLO). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Yariv Houvras submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.